The Economic Times daily newspaper is available online now.

    Welcure Drugs & Pharma board to consider share split, bonus issue this month

    Synopsis

    Welcure Drugs & Pharmaceuticals is set to consider a stock split of 1:10 and a bonus issue of 1:1 in its upcoming board meeting on August 22. This decision follows strong financial results in Q1 FY26, with revenue from operations reaching Rs 299.91 crore and net profit surging to Rs 23.29 crore.

    Welcure Drug and PharmaceuticalsAgencies
    Representational image
    MSME 2025
    New Delhi: Welcure Drugs & Pharmaceuticals on Monday said its board will meet on August 22 to consider a proposal of division of equity shares and a bonus issue.

    In a stock exchange filing, Welcure said it has proposed sub-division of the company's equity shares in the ratio of 1:10 -- stock split of one equity share into 10 equity shares.

    The board will also consider a proposal for the issue of one bonus equity share for every one share held by shareholders, the filing said.


    The move is aimed at enhancing liquidity and broadening shareholding following the company's stellar financial results in the first quarter of FY26.

    The company has reported revenue from operations of Rs 299.91 crore in April-June FY26, up from Rs 21.21 crore in the previous quarter. Net profit surged to Rs 23.29 crore in the first quarter of 2025-26.

    Add ET Logo as a Reliable and Trusted News Source
    Earlier, the company had completed seven export-sourcing assignments totalling Rs 299.91 crore.


    (You can now subscribe to our Economic Times WhatsApp channel)

    (Catch all the Business News, Breaking News, Budget 2025  Events and Latest News Updates on The Economic Times.)

    Subscribe to The Economic Times Prime and read the ET ePaper online.

    ...more
    The Economic Times

    Stories you might be interested in